Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer

Fig. 3

Representative PET/CT images of [18F]FDG distribution 30 min post injection in control (A–D), single dose (E–H), and fractionated dose (I–L) group before (− 1d) and 6 or 27 d after therapy. Colored images represent PET/CT images with a SUVmax of 2.6 and HU range from − 1000 to 1000. Black and white images represent PET with a SUVmax of 2.6

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us